...J. Carvalho de Sousa; E. Bruckert; P. Giral; C. Soria; J. Truffert; M.C. Mirshahi; J.L. de Gennes; J.P. Caen There is evidence that the increase in coagulation factor VII (FVII) represents a predictive risk factor of arterial thrombosis in coronary heart disease. Its relative contribution...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Factor VII Tissue factor Calcium ions Ca 2+ Hæ m otttaKi* Session II: Regulation of the Initiation of Haemostasis Haemostasis 1996;26(suppl 1...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Factor VII Factor VIla Plasma...

...E.G.D. Tuddenham Localised extravascular initiation of mammalian haemostasis is achieved by the anatomical localization of tissue factor (TF) around blood vessels and at organ surfaces. TF avidly binds factor VII from outflowing blood following vascular injury, forming the tissue factor/factor VII...

...Eric Camerer; Hans Prydz Tissue factor is both a trigger of blood coagulation and a true receptor inducing an intracellular signal upon binding of its ligand factor VII to its extracellular parts. When induced in endothelial cells more than 75% of tissue factor antigen was found on the apical side...

...Vijaya Mohan Rao; Samuel I. Rapaport Binding of factor VII to tissue factor (TF) present on or released from cells initiates TF-dependent coagulation in vivo. Earlier data obtained with relipidated TF suspensions led to the hypothesis that all factor VII bound to limiting TF sites exposed after...

...C. Biron; C. Bengler; J.C. Gris; J.F. Schved Isolated acquired factor VII deficiency is uncommon. We report 11 cases of acquired factor VII deficiency associated with severe systemic sepsis. All patients initially displayed a heterozygous-like factor VII deficiency confirmed by both clotting...

...A. Ferster; V. Capouet; A. Deville; P. Fondu; F. Corazza We describe here successful open heart surgery with extarcor-poreal circulation and haemodilution in a child with severe congenital factor VII deficiency. Substitution therapy was realized with factor VII concentrate (SD proconvertin...

.... Extrinsic pathway inhibitor Thromboplastin (tissue factor) Factor VII Coagulation inhibitors Anticoagulants Abstract. Extrinsic pathway inhibitor (EPI) is a Kunitz type serine protease inhibitor. EPI is a potent inhibitor of the factor Vlla/thromboplastin (TP) complex in the presence of factor Xa...

... to in the content or advertisements. Factor VII Hemophilia Joint bleeds Anti-FVIII:C FVIII bypassing Haemostasis 1989;19:335-343 ©1989 S. Kargcr AG, Basel O3OI-0I47/89/0196-O335S2.75/O Clinical Experience with Human Plasma-Derived Factor Vila in Patients with Hemophilia A and High Titer Inhibitors U...

...A. Gringeri; E. Santagostino; P.M. Mannucci Recombinant activated factor VII (rFVIIa) was used before and after inguinal hernioplasty to prevent bleeding in a patient with hemophilia A complicated by a high-potency antifactor VIII inhibitor. rFVIIa (75 μg/kg) was given before and after surgery...

... found reduced antithrombin III and factor VII levels in all the patients, in line with the results of other authors, and other slight and less constant changes such as lowered factor X activity and protein C antigen, and increased β-thromboglobulin levels. During pyridoxine and folate treatment...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Septicemia Coagulation inhibitors Extrinsic pathway inhibitor Tissue thromboplastin Factor VII Original Papers Haemostasis 1989;19:189-195 © 1989 S. Karger AG, Basel...

...A. Nordøy; D.R. Illingworth; W.E. Connor; S. Goodnight, Jr Coagulation factor VII and factor VII-phospholipid complex (factor VII p1 ), an activated form of factor VII, were measured using a Normotest system in 128 patients with various types of hyperlipoproteinemias and in 45 control subjects...

...J. Carvalho de Sousa; E. Bruckert; P. Giral; C. Soria; J. Chapman; J. Truffert; F. Dairou; J.L. De Gennes; J.P. Caen High circulating levels of coagulation factor VII (FVII) are known to be associated with elevated concentrations of blood lipids. More specifically, hypertriglyceridemia...

... neutralization assay; factor VII activity (VIl:C) was determined by one-stage assay with human factor VII artificially depleted plasma. All the patients showed increased levels of VIl:C and VIl·Ag compared to the reference population (p < 0.001). There is a significant correlation between VIl:C and VIl:Ag (r...

...A. Pardo; J.P. Oteyza; L. Blanco; M.A. Correa; J. Cesar; J.L. Steegman; M. Tamayo; I. Fernandez; L. Escribano; J.L. Navarro Twenty-three patients with congenital factor VII (FVII) deficiency, belonging to 9 kindreds were studied. Immunological variants were classified according to the relationship...

...Yale Nemerson Factor VII, a single-chain zymogen, has sufficient proteolytic activity to initiate blood coagulation. The reason that coagulation does not occur continuously is that the zymogen like its 2-chain derivative enzyme, factor VII a , absolutely requires tissue factor. The latter, a lipid...

...W.A. van Deijk; M.C.E. van Dam-Mieras; A.D. Muller; H.C. Hemker A coagulation assay is described that allows the measurement of the degree of activation of factor VII in circulating blood. The test is based on the use of both bovine and human brain thromboplastin, together with an artificial factor...

...H. Prydz A brief review of the interactions of the intrinsic and extrinsic coagulation pathways is given. The complex of thromboplastin and factor VII may well be the most important trigger in both pathways. 21 4 2009 © 1983 S. Karger AG, Basel 1983 Copyright / Drug Dosage...